The Cooper Companies, Inc

Healthcare · Medical Instruments & Supplies

54.80$ -3.0% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Income Statement

The Cooper Companies, Inc (COO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,066 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement COO
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	519	499	522	556	562	590	631	660	652	628	654	679	692	646	525	578	682	681	720	763	759	787	830	843	848	859	877	930	927	932	943	1,003	1,018	965	1,002	1,060	1,065	1,024	1,082	1,066	4,237
Cost of Revenue	223	187	179	200	208	219	227	233	221	210	222	229	237	220	201	217	258	230	232	247	257	269	297	291	312	300	295	320	321	308	311	340	341	305	323	368	464	329	346	401	1,540
Gross Profit	296	312	344	356	353	371	405	427	430	419	433	451	455	427	324	361	424	451	487	516	502	518	533	552	537	559	583	610	607	624	631	663	678	660	679	692	601	695	735	665	2,697
Research & Development	18	16	17	18	19	19	21	23	23	21	21	22	23	22	24	22	26	21	21	25	26	26	26	29	29	32	33	37	37	40	39	39	38	41	46	45	41	44	43	42	170
Selling, General & Administrative	189	189	193	209	209	226	248	251	249	250	247	250	250	258	237	233	264	261	286	353	312	319	322	343	358	331	408	375	388	381	380	381	391	388	399	422	419	390	676	401	1,887
Total Operating Expenses	222	222	227	243	245	281	305	311	307	308	305	309	308	315	295	289	324	317	344	416	373	388	400	412	433	409	487	458	471	471	470	471	479	478	494	516	461	482	766	443	2,152
Operating Income	74	91	117	113	109	90	75	116	123	111	147	142	147	111	29	72	100	133	143	101	129	131	133	141	104	150	96	152	136	153	162	193	198	182	185	176	140	213	-31	222	545
Interest Expense	5.3	7.3	7.7	8.3	10	18	19	23	23	18	19	17	15	12	13	5.7	6.7	6.4	6.1	5.6	5.0	6.6	11	17	23	26	26	27	26	30	29	29	27	26	33	25	24	22	21	27	95
Pre-Tax Income	69	80	110	108	97	75	54	90	113	94	128	127	129	97	9.0	66	94	140	136	94	122	122	164	117	72	122	66	119	106	120	130	164	169	153	145	152	117	192	-48	202	462
Income Tax Expense	8.4	4.3	4.6	4.1	8.0	197	-6.9	-10	12	-9.4	5.7	6.9	7.5	6.9	-2.5	11	13	-1,962	19	-522	11	27	37	19	6.8	38	26	34	22	39	41	59	51	49	57	54	32	61	30	-231	-108
Net Income	61	76	105	104	89	-123	61	101	101	103	122	120	121	91	12	55	81	2,101	118	616	110	95	127	98	66	85	40	85	85	81	89	105	118	104	88	98	85	131	-78	433	570
EBITDA	122	135	163	163	154	160	142	182	206	181	217	214	214	180	91	143	178	221	220	179	204	211	268	216	184	238	183	240	225	247	257	281	287	270	261	273	215	310	68	317	910

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings